REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,424,026 | +88.8% | 484,972 | +82.4% | 0.00% | +100.0% |
| Q2 2023 | $7,110,685 | -13.4% | 265,820 | -29.8% | 0.00% | 0.0% |
| Q1 2023 | $8,207,472 | +318.0% | 378,923 | +359.6% | 0.00% | – |
| Q4 2022 | $1,963,697 | -23.0% | 82,439 | -36.2% | 0.00% | -100.0% |
| Q3 2022 | $2,550,000 | +565.8% | 129,298 | +558.4% | 0.00% | – |
| Q2 2022 | $383,000 | -82.7% | 19,639 | -77.4% | 0.00% | – |
| Q1 2022 | $2,217,000 | -66.7% | 86,921 | -67.2% | 0.00% | – |
| Q4 2021 | $6,664,000 | +101.5% | 264,712 | +120.1% | 0.00% | – |
| Q3 2021 | $3,308,000 | +1.9% | 120,246 | +17.6% | 0.00% | – |
| Q2 2021 | $3,246,000 | -68.7% | 102,267 | -54.8% | 0.00% | -100.0% |
| Q1 2021 | $10,376,000 | +785.3% | 226,151 | +663.9% | 0.00% | – |
| Q4 2020 | $1,172,000 | +298.6% | 29,606 | +250.7% | 0.00% | – |
| Q3 2020 | $294,000 | -51.0% | 8,442 | -69.2% | 0.00% | – |
| Q1 2020 | $600,000 | – | 27,394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |